The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.
Many pharmacies and safety-net providers were preparing for the long-anticipated transition from Medicaid managed care to fee-for-service (FFS)—known as the carve-out—that was set to take effect on May 1, 2021.
High nonadherence in the US leads to avoidable mortality.
Monitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.
Biomarkers are commonly used by physicians to assist in the earlier diagnosis of some of the most common fungal diseases.
The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.
Addressing complacency, confidence, and convenience are all crucial to increasing vaccine uptake.
As the data management landscape continues to shift and change with AI and technological advancements all around us, it is essential to maintain good data practices and ensure data integrity in pharmaceutical research and development.
Validating language proficiency in bilingual pharmacists is crucial for patient safety and communication.
Specialty pharmacists play critical role in supporting treatment adherence.
Low compensation, stressful environment spark technician exodus; replacing them has been difficult.
Antibiotic prescribing at hospital discharge is a component of pharmacist-led antimicrobial stewardship programs that is often overlooked.
Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
Although frontotemporal dementia is the leading cause of the disease for those under 65 years of age, far fewer people are familiar with it than with Alzheimer disease.
Bhavesh Shah, RPh, BCOP, and Ryan Jacobs, MD, discuss emerging agents in the pipeline and the future treatment landscape for CLL.
Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Concepts could be used in payer-pharmacy value-based arrangements.
Research shows receipt of medications for chronic conditions was relatively stable in the first 2 years of the pandemic from 2020 to 2021 across racial and ethnic groups.
ADHD Awareness Months brings attention to a common, but still somewhat misunderstood condition that pharmacists encounter on a near daily basis.
Pharmacists can help address the significant asthma health disparities among racial, ethnic, and socioeconomic groups to help improve outcomes.
Metformin may accelerate paclitaxel’s actions on cell replication in endometrial cancer.
Pharmacists will play a significant role in TKI adherence rates among patients.
CGM enhances diabetes management in pregnancy, improving outcomes.
With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.
Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Pharmacists will play a significant role in TKI adherence rates among patients.
Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Data have shown the potential for the therapy to treat several new conditions.